---
figid: PMC6448643__CLD-2-188-g001
figtitle: Illustration showing the activation of a T lymphocyte (via a three‐signal
  pathway) by an antigen‐presenting cell
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC6448643
filename: CLD-2-188-g001.jpg
figlink: /pmc/articles/PMC6448643/figure/fig1/
number: F1
caption: 'Illustration showing the activation of a T lymphocyte (via a three‐signal
  pathway) by an antigen‐presenting cell. Further details include the specific sites
  targeted by the CNIs (tacrolimus and cyclosporine) showing inhibition of IL‐2 production.
  Monoclonal antibodies (basiliximab and daclizumab) target the IL‐2 receptor, whereas
  sirolimus, everolimus, MPA, MMF, and azathioprine interfere with the proliferative
  phase in the cell cycle. Abbreviations: AP‐1, activator protein 1; IKK, inhibitor
  of nuclear factor kappa; IL, interleukin; JAK3, Janus kinase 3; MAP, mitogen‐activated
  protein; MHC, major histocompatibility complex; MMF, mycophenolate mofetil; MPA,
  mycophenolate sodium; mRNA, messenger RNA; mTOR, mammalian target of rapamycin;
  NF‐κB, nuclear factor kappa B; NFAT, nuclear factor of activated T cells; PI‐3K,
  phosphoinositide 3‐kinase; TCR, T cell receptor. Reprinted with permission from
  Liver Transplantation. Copyright 2005, American Association for the Study of Liver
  Disease.'
papertitle: 'Immunosuppression: Conventions and controversies,  .'
reftext: Neil Mehta, et al. Clin Liver Dis (Hoboken). 2013 Aug;2(4):188-191.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9310275
figid_alias: PMC6448643__F1
figtype: Figure
redirect_from: /figures/PMC6448643__F1
ndex: 94f284ea-df0a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6448643__CLD-2-188-g001.html
  '@type': Dataset
  description: 'Illustration showing the activation of a T lymphocyte (via a three‐signal
    pathway) by an antigen‐presenting cell. Further details include the specific sites
    targeted by the CNIs (tacrolimus and cyclosporine) showing inhibition of IL‐2
    production. Monoclonal antibodies (basiliximab and daclizumab) target the IL‐2
    receptor, whereas sirolimus, everolimus, MPA, MMF, and azathioprine interfere
    with the proliferative phase in the cell cycle. Abbreviations: AP‐1, activator
    protein 1; IKK, inhibitor of nuclear factor kappa; IL, interleukin; JAK3, Janus
    kinase 3; MAP, mitogen‐activated protein; MHC, major histocompatibility complex;
    MMF, mycophenolate mofetil; MPA, mycophenolate sodium; mRNA, messenger RNA; mTOR,
    mammalian target of rapamycin; NF‐κB, nuclear factor kappa B; NFAT, nuclear factor
    of activated T cells; PI‐3K, phosphoinositide 3‐kinase; TCR, T cell receptor.
    Reprinted with permission from Liver Transplantation. Copyright 2005, American
    Association for the Study of Liver Disease.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - cd40
  - jak3
  - gnaia
  - cd28
  - mtor
  - kita
  - ngfra
  - mbtps1
  - CD40
  - IL2RA
  - ISG20
  - JAK3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CD28
  - MTOR
  - STK16
  - TAOK2
  - WNK1
  - OAT
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - DCLK1
  - ADGRL1
  - CLU
  - AKR1C4
  - GZMB
  - POLR3K
  - ZNF346
  - SELP
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - MBTPS1
---
